Literature DB >> 20954721

Triterpenoidal alkaloids from Buxus natalensis and their acetylcholinesterase inhibitory activity.

Wadim L Matochko1, Abin James, Cheuk W Lam, Daniel J Kozera, Athar Ata, Robert M Gengan.   

Abstract

Acetylcholinesterase (AChE) inhibition-directed phytochemical studies on the methanolic extract of Buxus natalensis, collected in South Africa, resulted in the isolation of 12 compounds: O(2)-natafuranamine (1), O(10)-natafuranamine (2), cyclonataminol (3), 31-demethylbuxaminol A (4), buxaminol A (5), buxafuranamide (6), buxalongifolamidine (7), buxamine A (8), cyclobuxophylline K (9), buxaminol C (10), methyl syringate (11), and p-coumaroylputrescine (12). Compounds 1-4 were new alkaloids, and compound 5 was isolated for the first time as a natural product. Their structures were elucidated with the aid of extensive NMR and mass spectroscopic studies. Compounds 1 and 2 are members of a rarely occurring class of Buxus alkaloids, having a tetrahydrofuran ring incorporated in their structures. Compounds 1-12 exhibited strong to moderate AChE inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20954721     DOI: 10.1021/np100494u

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  3 in total

Review 1.  Chemistry and bioactivities of natural steroidal alkaloids.

Authors:  Mei-Ling Xiang; Bin-Yuan Hu; Zi-Heng Qi; Xiao-Na Wang; Tian-Zhen Xie; Zhao-Jie Wang; Dan-Yu Ma; Qi Zeng; Xiao-Dong Luo
Journal:  Nat Prod Bioprospect       Date:  2022-06-15

2.  Acetonic extract of Buxus sempervirens induces cell cycle arrest, apoptosis and autophagy in breast cancer cells.

Authors:  Ouardia Ait-Mohamed; Valentine Battisti; Véronique Joliot; Lauriane Fritsch; Julien Pontis; Souhila Medjkane; Catherine Redeuilh; Aazdine Lamouri; Christine Fahy; Mohamed Rholam; Djebbar Atmani; Slimane Ait-Si-Ali
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

3.  Natural AChE Inhibitors from Plants and their Contribution to Alzheimer's Disease Therapy.

Authors:  Ana Paula Murray; María Belén Faraoni; María Julia Castro; Natalia Paola Alza; Valeria Cavallaro
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.